CN102108130A - Surface biological functionalization method for hydrophobic medical high polymer materials - Google Patents
Surface biological functionalization method for hydrophobic medical high polymer materials Download PDFInfo
- Publication number
- CN102108130A CN102108130A CN 201110037602 CN201110037602A CN102108130A CN 102108130 A CN102108130 A CN 102108130A CN 201110037602 CN201110037602 CN 201110037602 CN 201110037602 A CN201110037602 A CN 201110037602A CN 102108130 A CN102108130 A CN 102108130A
- Authority
- CN
- China
- Prior art keywords
- phbv
- amino
- bifunctional peg
- macromolecular materials
- rgd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
A major part of medical high polymer materials are hydrophobic and do not have bioactivity, so it is very necessary to perform the biological functionalization modification of the surface of the medical high polymer materials so as to improve the biological compatibility of the materials. By taking poly(hydroxybutyrate-hydroxyvalerate) (PHBV) which is a non-immunogenic biological material for example, the inventor provides the surface biological functionalization method for the hydrophobic medical high polymer materials. Through ammonia plasma treatment or modifying dopamine, amino can be introduced onto the surface of the PHBV, and consequently the surface of the PHBV can be modified with polyethylene glycol molecules (NHS-PEG-MAL) with different functional groups at terminal and short peptides containing arginine-glycine-aspatic acid (RGD). In-vitro cell experiments and protein absorption experiments prove that the biological compatibility of the modified PHBV is improved obviously. The introduced RGD short peptides can promote the growth of the cells on the surface of the material. Meanwhile, the PEG molecules have nonspecific protein absorption resisting capability, and therefore can prevent the generation of inflammation and the formation of thrombi.
Description
Technical field
What the present invention relates to is a kind of hydrophobicity medical macromolecular materials surface biological functional modification method, belongs to biomedical materials field.
Technical background
In organizational project, biomaterial is widely used in rack making.These supports not only provide mechanical support and 3D structure for cell, the signal that also provides induced tissue to form simultaneously.The structure of material, form, degraded and providing of biological activity site all are important design parameter, they all may influence the proliferation and differentiation of cell.Material surface also can be modified special biologically active substance to improve its biocompatibility.As connect the adhesion that arginine-glycine-aspartic acid (RGD) small peptide promotes cell at biomaterial surface.The RGD small peptide extensively is present in the extracellular matrix protein (as fibronectin, collagen protein and vitronectin etc.), but thereby the integrin site is connected to the cell grappling on the extracellular matrix on the specific recognition cytolemma.After being connected on the RGD small peptide, integrin can cause that thereby the variation of intracellular signaling pathway influences the propagation of cell, behaviors such as differentiation.In addition, material surface can also by modify heparin, polyoxyethylene glycol (PEG) wait and improve its anti-nonspecific proteins adsorptive power, and then reduces inflammation and takes place and thrombosis, this method is widely used in the finishing of the property implanted material such as blood vessel reparation.Polyhydroxybutyrate valeric acid copolyesters (PHBV) is a kind of good medical macromolecular materials, has biodegradability, no antigen and nontoxic, and non-carcinogenesis is subjected to extensive concern in recent years.Yet the same with most macromolecule polymer materials, the PHBV material surface is hydrophobic and lack the cell recognition site.In order further to improve the biocompatibility of PHBV, just need to change its surface property, introduce bioactive molecules, thereby reach the promotion cell adhesion, breed and increase the purpose of its anti-nonspecific proteins adsorptive power.This method can be applied to the surface modification of other hydrophobicity medical macromolecular materials equally to improve biocompatibility.
Summary of the invention
Technical problem:The object of the present invention is to provide a kind of surface modification method of hydrophobicity medical macromolecular materials, to improve the biocompatibility of material.
Technical scheme:The surface biological functional method of hydrophobicity medical macromolecular materials provided by the invention is:
At first, chosen medical macromolecular materials polyhydroxybutyrate valeric acid copolyesters PHBV, its surface hydrophobicity and reactionless avtive spot; Secondly, by Cement Composite Treated by Plasma or modification Dopamine HCL, introduce amino on the PHBV surface, carry out subsequent reactions by surface amino groups, modify successively and go up bifunctional PEG and contain the RGD small peptide, increase the active absorption that reduces nonspecific proteins simultaneously of superficial cell, improving the biocompatibility of PHBV.
Introducing amino method on the PHBV surface is: handle or modify Dopamine HCL by ammonia plasma treatment and realize; The PHBV film feeds ammonia to 50 Pa be evacuated to 7 Pa in plasma cleaner after, handles 120 sec under 60 W intensity, introduces amino on the surface; Or, the PHBV film is immersed in 24 h in the 2 mg/mL dopamine solution under room temperature, introduce amino on the surface.
Method at bifunctional PEG in the polyhydroxybutyrate valeric acid copolyesters PHBV modification is: the PHBV after will being modified with amino is immersed in 1 h in the 2 mM bifunctional PEG reaction solns under room temperature, and bifunctional PEG is covalently bound to the surface.
The method that contains the RGD small peptide in modification on the bifunctional PEG is: the PHBV film after will modifying bifunctional PEG is immersed in 5 h in the 50 μ g/mL RGD small peptide solution under room temperature, and the RGD small peptide is covalently bound to the surface.
Beneficial effect:The invention has the advantages that by easy method on hydrophobicity medical macromolecular materials surface
Introduce active function groups, and then modify PEG molecule with anti-nonspecific proteins absorption and the RGD small peptide that can promote the cell growth successively, thereby significantly improve raw-material biocompatibility by this functional group.
Description of drawings
Fig. 1 is the synoptic diagram of PHBV membrane prepare and surface biological functional method.
Fig. 2 is the active comparison of PHBV film superficial cell before and after modifying.
Fig. 3 is the comparison of the former adsorptive power of PHBV film surface antifibrin before and after modifying.
Fig. 4 is the comparison of PHBV film surface antiserum(antisera) protein adsorption ability before and after modifying.
Embodiment
1) prepares the PHBV film with spin-coating method; PHBV is dissolved in chloroform, and concentration is 10 (w/v) %, and is even by magnetic stirrer.Prepare the PHBV film with spin-coating method in surface of glass slide: with clean slide (Φ: 10 mm) place sol evenning machine, get 60 μ L PHBV drips of solution to surface of glass slide, with 4000 rpm spin coatings, 30 sec.Then spin coating there is the slide of PHBV film to put into 60 ℃ of vacuum-dryings of vacuum drying oven and spends the night, remove remaining chloroform.
2) at PHBV film finishing amino: (a) introduce amino by ammonia plasma treatment method treat surface: the PHBV film for preparing is put into plasma cleaner, be evacuated to 7 Pa, feed ammonia to 50 Pa, 60 W handle 120 sec.Perhaps (b) introduces amino by Dopamine HCL on the surface: get 40 mg Dopamine HCLs and be dissolved in 20 mL, 10 mM Tris-HCl damping fluids (pH 8.5) and be made into reaction solution, the PHBV film is put into reaction solution, reaction 24 h under the room temperature, the back dries up with a large amount of ultrapure water flushing surfaces and with nitrogen.
3) be modified with amino PHBV film finishing NHS-PEG-MAL: NHS-PEG-MAL is dissolved in HEPES-NaCl damping fluid (pH 7.2 for 10 mM HEPES, 150 mM NaCl), is made into the reaction solution that concentration is 2 mM; Immerse in the reaction solution reaction 1 h under the room temperature, the back unreacted NHS-PEG-MAL solution of ultrapure water flush away with being modified with amino PHBV film.
4) introduce GRGDSPC after modifying NHS-PEG-MAL: GRGDSPC is dissolved in HEPES-NaCl-EDTA damping fluid (5 mM EDTA, pH 6.8 for 10 mM HEPES, 150 mM NaCl), and concentration is 50 μ g/mL; PHBV film behind the modification NHS-PEG-MAL is immersed in this solution reaction 5 h under room temperature, the GRGDSPC of back on the ultrapure water flush away unreacted.
5) each step is reacted the back by contact angle, and XPS detects proof PHBV surface and successfully modifies amino, NHS-PEG-MAL and GRGDSPC, and after soaking 3 days, surface group is stable.Obviously strengthen (Fig. 2) from NIH 3T3 cell culture experiments and nonspecific proteins adsorption experiment are provable modifying RGD rear surface cytoactive than the surface of unmodified; Modify the anti-nonspecific proteins adsorptive power in NHS-PEG-MAL rear surface and obviously strengthen, after introducing RGD, the surface still have this characteristic (Fig. 3, Fig. 4).So after this method modification, the biocompatibility of PHBV significantly improves.
Claims (4)
1. the surface biological functional method of hydrophobicity medical macromolecular materials is characterized in that: at first, chosen medical macromolecular materials polyhydroxybutyrate valeric acid copolyesters PHBV, its surface hydrophobicity and reactionless avtive spot; Secondly, by Cement Composite Treated by Plasma or modification Dopamine HCL, introduce amino on the PHBV surface, carry out subsequent reactions by surface amino groups, modify successively and go up bifunctional PEG and contain the RGD small peptide, increase the active absorption that reduces nonspecific proteins simultaneously of superficial cell, improving the biocompatibility of PHBV.
2. the surface biological functional method of hydrophobicity medical macromolecular materials according to claim 1 is characterized in that introducing amino method on the PHBV surface is: handle or modify Dopamine HCL by ammonia plasma treatment and realize; The PHBV film feeds ammonia to 50 Pa be evacuated to 7 Pa in plasma cleaner after, handles 120 sec under 60 W intensity, introduces amino on the surface; Or, the PHBV film is immersed in 24 h in the 2 mg/mL dopamine solution under room temperature, introduce amino on the surface.
3. the surface biological functional method of hydrophobicity medical macromolecular materials according to claim 1, it is characterized in that in the method for bifunctional PEG in the polyhydroxybutyrate valeric acid copolyesters PHBV modification being: the PHBV after will being modified with amino is immersed in 1 h in the 2 mM bifunctional PEG reaction solns under room temperature, and bifunctional PEG is covalently bound to the surface.
4. the surface biological functional method of hydrophobicity medical macromolecular materials according to claim 3, it is characterized in that the method that contains the RGD small peptide in modification on the bifunctional PEG is: the PHBV film after will modifying bifunctional PEG is immersed in 5 h in the 50 μ g/mL RGD small peptide solution under room temperature, and the RGD small peptide is covalently bound to the surface.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110037602 CN102108130A (en) | 2011-02-14 | 2011-02-14 | Surface biological functionalization method for hydrophobic medical high polymer materials |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110037602 CN102108130A (en) | 2011-02-14 | 2011-02-14 | Surface biological functionalization method for hydrophobic medical high polymer materials |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102108130A true CN102108130A (en) | 2011-06-29 |
Family
ID=44172424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110037602 Pending CN102108130A (en) | 2011-02-14 | 2011-02-14 | Surface biological functionalization method for hydrophobic medical high polymer materials |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102108130A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103316600A (en) * | 2013-05-14 | 2013-09-25 | 中国科学院宁波材料技术与工程研究所 | Method for fixing heparin on polylactic acid hemodialysis membrane surface |
WO2015127897A1 (en) * | 2014-02-27 | 2015-09-03 | 国玺干细胞应用技术股份有限公司 | Method for preparing hollow microparticle |
CN106519205A (en) * | 2016-10-26 | 2017-03-22 | 河南工程学院 | Preparation method and application of drug-loading porous PHBV grafted dopamine microparticles |
CN111671970A (en) * | 2020-07-30 | 2020-09-18 | 齐鲁工业大学 | Polypeptide single-layer film with primary amino group exposure of 7%, and preparation method and application thereof |
CN111671971A (en) * | 2020-07-30 | 2020-09-18 | 齐鲁工业大学 | Polypeptide single-layer film with 6% primary amino group exposure and preparation method and application thereof |
CN111871003A (en) * | 2020-07-31 | 2020-11-03 | 西南石油大学 | Bionic mussel-based super-hydrophobic metal net and preparation method and application thereof |
CN112717207A (en) * | 2020-12-15 | 2021-04-30 | 山东大学 | Long-acting antibacterial multifunctional coating based on bionic dopamine and preparation method and application thereof |
CN113123120A (en) * | 2021-05-24 | 2021-07-16 | 中山大学 | Preparation method and application of PET (polyethylene terephthalate) cell carrier capable of resisting high-temperature sterilization |
CN114177363A (en) * | 2021-12-14 | 2022-03-15 | 无锡中科光远生物材料有限公司 | Anti-adhesion fiber membrane for promoting endothelialization and preparation method thereof |
CN116328047A (en) * | 2022-12-22 | 2023-06-27 | 上海琦识医疗科技有限公司 | Precise medical catheter |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1302825A (en) * | 2001-01-08 | 2001-07-11 | 天津大学 | Process for modifying biological polyhydroxyester material with silk protein |
CN101955595A (en) * | 2010-08-11 | 2011-01-26 | 东南大学 | Method for guiding fixed-point cell growth by preparing chemical micro-patterns on surfaces of various materials |
-
2011
- 2011-02-14 CN CN 201110037602 patent/CN102108130A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1302825A (en) * | 2001-01-08 | 2001-07-11 | 天津大学 | Process for modifying biological polyhydroxyester material with silk protein |
CN101955595A (en) * | 2010-08-11 | 2011-01-26 | 东南大学 | Method for guiding fixed-point cell growth by preparing chemical micro-patterns on surfaces of various materials |
Non-Patent Citations (1)
Title |
---|
《Biomacromolecules》 20110204 Yan-Yan Wang等 Introducing RGD Peptides on PHBV Films through PEG-Containing Cross-Linkers to Improve the Biocompatibility 第551-559页 1-4 第12卷, 第3期 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103316600A (en) * | 2013-05-14 | 2013-09-25 | 中国科学院宁波材料技术与工程研究所 | Method for fixing heparin on polylactic acid hemodialysis membrane surface |
CN103316600B (en) * | 2013-05-14 | 2015-03-25 | 中国科学院宁波材料技术与工程研究所 | Method for fixing heparin on polylactic acid hemodialysis membrane surface |
WO2015127897A1 (en) * | 2014-02-27 | 2015-09-03 | 国玺干细胞应用技术股份有限公司 | Method for preparing hollow microparticle |
CN106519205A (en) * | 2016-10-26 | 2017-03-22 | 河南工程学院 | Preparation method and application of drug-loading porous PHBV grafted dopamine microparticles |
CN111671970B (en) * | 2020-07-30 | 2021-12-14 | 齐鲁工业大学 | Polypeptide single-layer film with primary amino group exposure of 7%, and preparation method and application thereof |
CN111671971A (en) * | 2020-07-30 | 2020-09-18 | 齐鲁工业大学 | Polypeptide single-layer film with 6% primary amino group exposure and preparation method and application thereof |
CN111671970A (en) * | 2020-07-30 | 2020-09-18 | 齐鲁工业大学 | Polypeptide single-layer film with primary amino group exposure of 7%, and preparation method and application thereof |
CN111671971B (en) * | 2020-07-30 | 2022-01-25 | 齐鲁工业大学 | Polypeptide single-layer film with 6% primary amino group exposure and preparation method and application thereof |
CN111871003A (en) * | 2020-07-31 | 2020-11-03 | 西南石油大学 | Bionic mussel-based super-hydrophobic metal net and preparation method and application thereof |
CN112717207A (en) * | 2020-12-15 | 2021-04-30 | 山东大学 | Long-acting antibacterial multifunctional coating based on bionic dopamine and preparation method and application thereof |
CN113123120A (en) * | 2021-05-24 | 2021-07-16 | 中山大学 | Preparation method and application of PET (polyethylene terephthalate) cell carrier capable of resisting high-temperature sterilization |
CN113123120B (en) * | 2021-05-24 | 2022-05-27 | 中山大学 | Preparation method and application of PET (polyethylene terephthalate) cell carrier capable of resisting high-temperature sterilization |
CN114177363A (en) * | 2021-12-14 | 2022-03-15 | 无锡中科光远生物材料有限公司 | Anti-adhesion fiber membrane for promoting endothelialization and preparation method thereof |
CN116328047A (en) * | 2022-12-22 | 2023-06-27 | 上海琦识医疗科技有限公司 | Precise medical catheter |
CN116328047B (en) * | 2022-12-22 | 2023-10-10 | 上海琦识医疗科技有限公司 | Precise medical catheter |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102108130A (en) | Surface biological functionalization method for hydrophobic medical high polymer materials | |
Chen et al. | Impact of antifouling PEG layer on the performance of functional peptides in regulating cell behaviors | |
Rahmati et al. | Protein adsorption on polymers | |
Ghosh et al. | Arginine-presenting peptide hydrogels decorated with hydroxyapatite as biomimetic scaffolds for bone regeneration | |
Swartzlander et al. | Linking the foreign body response and protein adsorption to PEG-based hydrogels using proteomics | |
Delaittre et al. | Chemical approaches to synthetic polymer surface biofunctionalization for targeted cell adhesion using small binding motifs | |
Tada et al. | Design and synthesis of binding growth factors | |
CN103191469B (en) | Method for preparing coating carrying growth factor on surface of bone injury repair material | |
Phan et al. | In vitro biocompatibility of decellularized cultured plant cell-derived matrices | |
CN103041445A (en) | Method for preparing molecular imprinting porous gel membrane for tissue engineering | |
Chuang et al. | Enzymatic regulation of functional vascular networks using gelatin hydrogels | |
Shafiq et al. | In situ vascular regeneration using substance P-immobilised poly (L-lactide-co-ε-caprolactone) scaffolds: stem cell recruitment, angiogenesis, and tissue regeneration | |
CN103894328B (en) | The method of the nano particle of laminin and SDF-1 α is taken in the assembling of Ti material surface | |
CN1694955A (en) | Programmable scaffold and methods for making and using the same | |
US10814285B2 (en) | Functionalized membranes for bioartificial organs | |
Shafiq et al. | Stem cell recruitment, angiogenesis, and tissue regeneration in substance P‐conjugated poly (l‐lactide‐co‐ɛ‐caprolactone) nonwoven meshes | |
Wei et al. | Aptamer/Hydroxyapatite-Functionalized Titanium substrate promotes Implant Osseointegration via recruiting mesenchymal stem cells | |
Yan et al. | In vitro evaluation of the biological performance of macro/micro‐porous silk fibroin and silk‐nano calcium phosphate scaffolds | |
Han et al. | In vivo biocompatibility of sulfonated PEO‐grafted polyurethanes for polymer heart valve and vascular graft | |
CN105327406A (en) | Method for preparing multi-layer heparin-carrying reduced graphene oxide coating | |
CN104383611A (en) | Method for preparing medicine loading coating by assembling poly-electrolytes | |
CN104028434B (en) | A kind of method at the laminin/heparin/SDF-1 α anti-freezing of titanium surface construction and inducing endothelial Multifunctional layered | |
Iravani et al. | Cellulose-based composites as scaffolds for tissue engineering: recent advances | |
Dutta et al. | Effect of collagen nanofibers and silanization on the interaction of HaCaT keratinocytes and 3T3 fibroblasts with alumina nanopores | |
Balavigneswaran et al. | Silica release from silane cross-linked gelatin based hybrid scaffold affects cell proliferation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110629 |